ARCHIVES

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Dexamethasone Improved Survival Of Leukemia

November 26, 2004